Hong Kong Pharmaceuticals Stock News

Bank of China (SEHK:3988) completed a RMB 50 billion write down Tier 2 capital bond issuance at a 1.97% coupon. This event puts its capital position and funding costs in clearer focus for shareholders. See our latest analysis for Bank of China. The recent RMB 50 billion Tier 2 bond issue comes as the HK$5.18 share price sits on a 30 day share price return of 5.93%. The 1 year total shareholder return of 22.52% and 5 year total shareholder return of 150.36% suggest momentum has been building...

Jiangxi Copper Company Limited reported first-quarter 2026 results, with revenue rising to CNY 139,124.07 million and net income reaching CNY 2,817.56 million, both higher than a year earlier. The jump in basic earnings per share from CNY 0.57 to CNY 0.82 highlights improved profitability alongside the company’s expanded sales base. We’ll now consider how this earnings-driven profitability improvement shapes Jiangxi Copper’s investment narrative and what it may signal for investors. Rare...

Why Precision Tsugami (China) is back on investors’ radar Precision Tsugami (China) (SEHK:1651) said it expects profit attributable to owners for the year ended March 31, 2026 to reach about CN¥1,094 million, which is roughly 40% above the prior year’s CN¥782 million. See our latest analysis for Precision Tsugami (China). Investors appear to have reacted quickly to the profit guidance, with the HK$48.06 share price supported by a 1 month share price return of 37.79% and a 1 year total...

Why Newborn Town’s Latest Revenue Guidance Matters Newborn Town (SEHK:9911) has issued unaudited Q1 2026 revenue guidance, indicating expected group revenue of RMB 2,030 million to RMB 2,130 million, described as roughly 33% to 39.6% year-on-year growth. The company attributes this performance to combined contributions from its social networking and so-called innovative business lines, which together continue to shape how investors might view the mix and scale of its operating model. See our...

J&T Global Express (SEHK:1519) is drawing attention after recent share price moves, with a 1 day decline, a small loss over the past week, and a gain over the past month. See our latest analysis for J&T Global Express. The recent 1 day and 7 day share price declines sit against a 30 day share price return of 11.23% and a 1 year total shareholder return of 67.22%. This suggests momentum has cooled in the short term after a stronger run. If you are comparing J&T Global Express with other...

RemeGen (SEHK:9995) opened 2026 with Q1 revenue of C¥656.2 million and basic EPS of C¥0.58, following a trailing twelve month stretch that produced total revenue of C¥3.4 billion and basic EPS of C¥2.33. The company has seen quarterly revenue move from C¥508.0 million in Q4 2024 to C¥526.0 million in Q1 2025, then to C¥656.2 million in Q1 2026. EPS shifted from a loss of C¥0.74 in Q4 2024 to a loss of C¥0.46 in Q1 2025 and then to a profit of C¥0.58 in the latest quarter, setting up a results...

Chongqing Rural Commercial Bank (SEHK:3618) opened Q1 2026 with total revenue of C¥6.6b and net income of C¥3.9b, translating to basic EPS of C¥0.35. Over recent quarters the bank has seen revenue move from C¥4.6b in Q4 2024 to C¥6.1b in Q1 2025 and C¥6.6b in the latest quarter. Quarterly EPS shifted from C¥0.09 to C¥0.33 and now C¥0.35, setting up a picture of solid top line scale and earnings power backed by firm margins. See our full analysis for Chongqing Rural Commercial Bank. With the...

If you are wondering whether Zhejiang Leapmotor Technology is attractively priced or if the recent share move signals a value trap, this article walks you through what the current valuation is really indicating. The stock last closed at HK$45.58, with a 15.4% decline over 7 days, a 6.8% decline over 30 days, an 8.0% decline year to date, a 36.3% return over 3 years, and a 16.9% decline over 1 year. Recent coverage has focused on how investors are reassessing electric vehicle makers listed in...

The most recent earnings report from BYD Electronic (International) Company Limited ( HKG:285 ) was disappointing for...

China Labor Watch has reported alleged labor violations at BYD's Hungarian factory, including poor working conditions and possible breaches of local labor laws. European lawmakers have called on the European Commission to investigate the allegations, increasing regulatory attention on BYD's European operations. The scrutiny comes as BYD, ticker SEHK:1211, continues to expand its presence in Europe. For investors watching BYD at a current share price of HK$103.7, the issue adds a fresh layer...

ZONQING Environmental Limited's ( HKG:1855 ) earnings announcement last week didn't impress shareholders. Despite the...

From what we can see, insiders were net buyers in Rizhao Port Jurong Co., Ltd.'s ( HKG:6117 ) during the past 12...

China East Education Holdings Limited ( HKG:667 ), might not be a large cap stock, but it received a lot of attention...

Over the last year, a good number of insiders have significantly increased their holdings in China Strategic Technology...

Insiders who bought CN¥1.49m worth of XJ International Holdings Co., Ltd.'s ( HKG:1765 ) stock at an average buy price...

China Shenhua Energy (SEHK:1088) has drawn attention after first quarter 2026 results showed net income of CN¥11,885 million, compared with CN¥13,374 million a year earlier. This has prompted fresh questions about how investors may reassess the stock. See our latest analysis for China Shenhua Energy. The first quarter earnings announcement, which showed net income easing to CN¥11,885 million from CN¥13,374 million, has not derailed interest in the stock. The 1 day share price return was 1.99%...

The latest analyst coverage could presage a bad day for Concord New Energy Group Limited ( HKG:182 ), with the analysts...

CITIC Limited's ( HKG:267 ) solid earnings announcement recently didn't do much to the stock price. We did some...

Daido Group Limited ( HKG:544 ) insiders who purchased shares in the last 12 months were richly rewarded last week. The...

BOE Varitronix Limited's ( HKG:710 ) recent weak earnings report didn't cause a big stock movement. However, we believe...

As global markets navigate through geopolitical uncertainties and economic shifts, Asia's financial landscape remains a focal point for investors seeking diverse opportunities. Penny stocks, despite their somewhat outdated moniker, continue to attract attention for their potential to offer growth at an accessible price point. These smaller or newer companies can present unique investment prospects when backed by solid financial health; let's explore some that stand out in this regard.

Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) has opened Q1 2026 with revenue of ¥433.1 million and basic EPS of ¥0.23, against a backdrop of trailing twelve month revenue of about ¥1.6 billion and basic EPS of ¥0.72 that has been associated with very large year over year earnings expansion and a higher net margin of 18.6% versus 7.6% a year earlier. Over recent periods, revenue has moved from ¥980.5 million on a trailing basis in Q4 2024 to ¥1.6 billion by Q1 2026, while quarterly EPS has...

Before deciding whether Tencent Holdings fits your portfolio, it helps to be clear on one thing: what are you really getting for the current share price, and does that look like good value to you? Tencent’s share price closed at HK$473.8 most recently, with returns of an 8.7% decline over 7 days, a 4.0% decline over 30 days, a 23.9% decline year to date, a 1.0% gain over 1 year, a 40.4% gain over 3 years and a 14.7% decline over 5 years. This signals mixed sentiment over different time...

What WuXi Biologics (Cayman) SEHK:2269 offers investors right now WuXi Biologics (Cayman) SEHK:2269 gives you exposure to a global contract research, development, and manufacturing business in biologics, backed by HK$21,790.018 million in revenue and HK$4,908.343 million in net income. See our latest analysis for WuXi Biologics (Cayman). At a share price of HK$33.7, WuXi Biologics (Cayman) has a 30 day share price return of 4.14%, while the 1 year total shareholder return of 45.89% contrasts...